Growth of PPHN PASMC was assessed in response to PPAR agonists [rosiglitazone (Rosi), 50 M, and 15-deoxy-delta12,14-prostaglandin J2 (PG-J2), 10 mM] (A) and normal PASMC assessed in response to PPAR inhibition (PPAR siRNA 4 M) (B)
Growth of PPHN PASMC was assessed in response to PPAR agonists [rosiglitazone (Rosi), 50 M, and 15-deoxy-delta12,14-prostaglandin J2 (PG-J2), 10 mM] (A) and normal PASMC assessed in response to PPAR…